Brolucizumab
CAS: 1531589-13-5
Ref. TM-T80593
| 1mg | 233.00 € | ||
| 5mg | 607.00 € | ||
| 10mg | 928.00 € | ||
| 25mg | 1,439.00 € | ||
| 50mg | 1,862.00 € | ||
| 100mg | 2,623.00 € |
Estimated delivery in United States, on Thursday 30 Jan 2025
Product Information
Name:
Brolucizumab
Synonyms:
- RTH258
- ESBA 1008
- DLX1008
Description:
Brolucizumab (DLX1008) is a single-chain anti-VEGF-A antibody fragment exhibiting low picomolar affinity (K D = 1.05 pM), utilized for cancer research [1] [2].
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Purity:
98%
Color/Form:
Liquid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T80593 Brolucizumab
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
